HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

XRP6258

in multicenter phase II study for treatment of taxane-resistant metastatic breast cancer patients (2008)
Networked: 4 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Pivot, X: 2 articles (05/2011 - 09/2008)
2. Villanueva, C: 1 article (05/2011)
3. Machiels, J P: 1 article (05/2011)
4. Magherini, E: 1 article (05/2011)
5. Awada, A: 1 article (05/2011)
6. Semiond, D: 1 article (05/2011)
7. Campone, M: 1 article (05/2011)
8. Dubin, F: 1 article (05/2011)
9. Besse, T: 1 article (05/2011)
10. Ensley, John F: 1 article (06/2010)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Related Drugs and Biologics

1. taxane
2. 4- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoate
3. capecitabine (Xeloda)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)